A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00546286
Recruitment Status : Completed
First Posted : October 18, 2007
Last Update Posted : April 4, 2017
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.